Login / Signup

Benefits of Switch from Oral to Subcutaneous Route on Adherence to Methotrexate in Patients with Rheumatoid Arthritis in Real Life Setting.

Eric SenbelSonia TropéHélène Herman-DemarsElena ZinovievaAgnès CourbeyrettePierre ClersonYann FardiniRené-Marc Flipo
Published in: Patient preference and adherence (2021)
Overall, change from oral to SC route improved adherence to MTX, RA control and quality of life independently of change in MTX dose.
Keyphrases
  • rheumatoid arthritis
  • high dose
  • glycemic control
  • type diabetes
  • insulin resistance
  • systemic lupus erythematosus
  • skeletal muscle
  • interstitial lung disease
  • systemic sclerosis